Medical imaging market seen reaching $66.02B by 2035

Market Research Future projects the global medical imaging market will grow from $41.99 billion in 2025 to $66.02 billion by 2035, driven by chronic disease growth, AI-enabled imaging and telemedicine. North America led the market in 2024 with more than 38% share, while MRI and CT remain central to demand.

Why it matters: - Demand for diagnostic imaging is tied to chronic disease, aging populations and earlier detection, making the market less cyclical than discretionary healthcare spending. - AI-integrated imaging tools and telemedicine are changing how scans are captured, interpreted and delivered across care settings. - The forecast points to continued capital spending on imaging equipment, software and services through 2035.

What happened: - Market Research Future projects the global medical imaging market will rise from $41.99 billion in 2025 to $66.02 billion by 2035. - The forecast implies a 4.63% compound annual growth rate over 2025–2035. - The market was valued at $40.13 billion in 2024. - North America held more than 38% of the market in 2024 and generated about $15.25 billion in revenue. - The report frames chronic disease burden, AI and machine learning adoption, and telemedicine expansion as the main growth drivers. - A free sample and detailed report are available from Market Research Future.

The details: - Chronic conditions such as cancer, cardiovascular disease and diabetes are increasing demand for MRI, CT and ultrasound. - The World Health Organization expects the global population aged 60 and older to double by 2050. - The Centers for Disease Control and Prevention says chronic diseases account for nearly 90% of U.S. healthcare spending. - AI and machine learning are improving image quality, diagnostic accuracy and workflow efficiency across imaging platforms. - AI-integrated MRI and CT systems gained rapid adoption in 2025, including real-time image reconstruction tools that reduce scan time and improve clarity. - Telemedicine is expanding remote consultation and interpretation, especially across Asia-Pacific. - MRI is the largest imaging technique segment and is projected to grow from $12.0 billion to $20.0 billion. - CT is the fastest-growing imaging technique. - Ultrasound is projected to grow from $8.0 billion to $12.0 billion by 2035. - Hospitals were the largest end-use segment in 2024, valued between $15.0 billion and $25.0 billion. - Diagnostic imaging centers were the fastest-growing end-use segment, valued between $10.0 billion and $15.0 billion in 2024. - Radiography is the dominant modality and is expected to grow from $10.0 billion to $16.0 billion. - MRI is the fastest-growing modality. - Equipment is the largest product-type segment and is projected to grow from $25.0 billion to $40.0 billion. - Consumables are the fastest-growing product-type segment. - Software is gaining importance as facilities add AI-enabled diagnostic and workflow tools. - North America is projected to reach $25.0 billion by 2035. - Europe was valued at $12.9 billion in 2024 and is projected to reach $20.0 billion by 2035. - Asia-Pacific was valued at $8.3 billion in 2024 and is expected to rise to $12.5 billion by 2035. - South America was valued at $2.4 billion in 2024 and is projected to reach $4.0 billion by 2035. - The Middle East and Africa was valued at $1.28 billion in 2024 and is expected to expand to $4.5 billion by 2035.

Between the lines: - The forecast suggests imaging growth is being driven by structural healthcare needs, not short-term demand spikes. - AI and cloud-based analytics are becoming competitive differentiators for manufacturers and software vendors. - Consolidation is part of the strategy, with Fujifilm Holdings and Agfa-Gevaert cited for acquisitions in 2023. - The market is shifting toward faster, more automated and more remote diagnostic workflows.

What's next: - AI-driven diagnostic tools are expected to become standard infrastructure in hospitals and diagnostic centers by 2035. - Portable imaging devices and point-of-care diagnostics represent additional growth opportunities. - Telemedicine-linked imaging services should continue to broaden access, especially in Asia-Pacific. - Preventive screening programs are likely to keep oncology and cardiology among the strongest use cases for imaging.

The bottom line: - Medical imaging is on track for steady expansion through 2035 as aging populations, chronic disease and AI adoption keep pushing demand higher.